Operating Income (Loss) of ACCENDRA HEALTH INC/VA/ from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
ACCENDRA HEALTH INC/VA/ quarterly and annual Operating Income (Loss) in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • ACCENDRA HEALTH INC/VA/ Operating Income (Loss) for the quarter ending 31 Dec 2025 was $40,576,000.
  • ACCENDRA HEALTH INC/VA/ Operating Income (Loss) for the twelve months ending 31 Dec 2025 was $27,460,000.
  • ACCENDRA HEALTH INC/VA/ annual Operating Income (Loss) for 2025 was $27,460,000.
  • ACCENDRA HEALTH INC/VA/ annual Operating Income (Loss) for 2024 was $217,730,000, a 263% decline from 2023.
  • ACCENDRA HEALTH INC/VA/ annual Operating Income (Loss) for 2023 was $133,231,000, a 6.8% decline from 2022.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

ACCENDRA HEALTH INC/VA/ Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $27,460,000 $40,576,000 +$316,003,000 01 Oct 2025 31 Dec 2025 10-K 20 Feb 2026 2025 FY
Q3 2025 $288,543,000 $26,470,000 -$4,609,000 -15% 01 Jul 2025 30 Sep 2025 10-Q 31 Oct 2025 2025 Q3
Q2 2025 $283,934,000 $39,710,000 -$56,632,000 -335% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $227,302,000 $124,000 -$9,572,000 -99% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $217,730,000 $275,427,000 -$364,171,000 -410% 01 Oct 2024 31 Dec 2024 10-K 20 Feb 2026 2025 FY
Q3 2024 $146,441,000 $31,079,000 +$7,238,000 +30% 01 Jul 2024 30 Sep 2024 10-Q 31 Oct 2025 2025 Q3
Q2 2024 $139,203,000 $16,922,000 +$6,083,000 +56% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $133,120,000 $9,696,000 -$111,000 -1.1% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $133,231,000 $88,744,000 +$142,222,000 01 Oct 2023 31 Dec 2023 10-K 20 Feb 2026 2025 FY
Q3 2023 $8,991,000 $23,841,000 -$36,406,000 -60% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024 2024 Q3
Q2 2023 $27,415,000 $10,839,000 -$64,246,000 -86% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024 2024 Q2
Q1 2023 $91,661,000 $9,807,000 -$51,252,000 -84% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024 2024 Q1
Q4 2022 $142,913,000 $53,478,000 -$115,500,000 -186% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
Q3 2022 $258,413,000 $60,247,000 -$2,628,000 -4.2% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023 2023 Q3
Q2 2022 $261,041,000 $75,085,000 -$21,799,000 -22% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023 2023 Q2
Q1 2022 $282,840,000 $61,059,000 -$85,633,000 -58% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q4 2021 $368,473,000 $62,022,000 -$33,591,000 -35% 01 Oct 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
Q3 2021 $402,064,000 $62,875,000 -$12,678,000 -17% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 $414,742,000 $96,884,000 +$74,688,000 +336% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $340,054,000 $146,692,000 +$135,936,000 +1264% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 $204,118,000 $95,613,000 +$81,075,000 +558% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $123,043,000 $75,553,000 +$49,443,000 +189% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 $73,600,000 $22,196,000 +$6,297,000 +40% 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021 2021 Q2
Q1 2020 $67,303,000 $10,756,000 -$5,848,000 -35% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q4 2019 $73,151,000 $14,538,000 +$240,407,000 01 Oct 2019 31 Dec 2019 10-K 23 Feb 2022 2021 FY
Q3 2019 $167,256,000 $26,110,000 +$4,753,000 +22% 01 Jul 2019 30 Sep 2019 10-Q 03 Nov 2020 2020 Q3
Q2 2019 $172,009,000 $15,899,000 +$187,950,000 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 $359,959,000 $16,604,000 -$7,613,000 -31% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q4 2018 $352,346,000 $225,869,000 -$217,095,000 -2474% 01 Oct 2018 31 Dec 2018 10-K 04 Mar 2020 2019 FY
Q3 2018 $135,251,000 $21,357,000 -$8,314,000 -28% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2019 Q3
Q2 2018 $126,937,000 $172,051,000 -$204,888,000 -624% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $77,951,000 $24,217,000 -$11,300,000 -32% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q4 2017 $89,251,000 $8,774,000 -$57,781,000 -118% 01 Oct 2017 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 $147,032,000 $29,671,000 -$23,897,000 -45% 01 Jul 2017 30 Sep 2017 10-Q 05 Nov 2018 2018 Q3
Q2 2017 $170,929,000 $32,837,000 -$19,217,000 -37% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018 2018 Q2
Q1 2017 $190,146,000 $35,517,000 -$9,453,000 -21% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 $199,599,000 $49,007,000 -$8,945,000 -15% 01 Oct 2016 31 Dec 2016 10-K 06 Mar 2019 2018 FY
Q3 2016 $208,544,000 $53,568,000 -$4,000 -0.01% 01 Jul 2016 30 Sep 2016 10-Q 02 Nov 2017 2017 Q3
Q2 2016 $208,548,000 $52,054,000 +$4,194,000 +8.8% 01 Apr 2016 30 Jun 2016 10-Q 02 Aug 2017 2017 Q2
Q1 2016 $204,354,000 $44,970,000 +$3,995,000 +9.8% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017 2017 Q1
Q4 2015 $200,359,000 $57,952,000 +$17,178,000 +42% 01 Oct 2015 31 Dec 2015 10-K 23 Feb 2018 2017 FY
Q3 2015 $183,181,000 $53,572,000 +$18,195,000 +51% 01 Jul 2015 30 Sep 2015 10-Q 02 Nov 2016 2016 Q3
Q2 2015 $164,986,000 $47,860,000 +$10,759,000 +29% 01 Apr 2015 30 Jun 2015 10-Q 03 Aug 2016 2016 Q2
Q1 2015 $154,227,000 $40,975,000 -$5,309,000 -11% 01 Jan 2015 31 Mar 2015 10-Q 04 May 2016 2016 Q1
Q4 2014 $159,536,000 $40,774,000 -$10,160,000 -20% 01 Oct 2014 31 Dec 2014 10-K 17 Feb 2017 2016 FY
Q3 2014 $169,696,000 $35,377,000 -$13,838,000 -28% 01 Jul 2014 30 Sep 2014 10-Q 28 Oct 2015 2015 Q3
Q2 2014 $183,534,000 $37,101,000 -$12,949,000 -26% 01 Apr 2014 30 Jun 2014 10-Q 28 Jul 2015 2015 Q2
Q1 2014 $196,483,000 $46,284,000 -$1,600,000 -3.3% 01 Jan 2014 31 Mar 2014 10-Q 28 Apr 2015 2015 Q1
Q4 2013 $198,083,000 $50,934,000 +$5,893,000 +13% 01 Oct 2013 31 Dec 2013 10-K 25 Feb 2016 2015 FY
Q3 2013 $192,190,000 $49,215,000 +$2,552,000 +5.5% 01 Jul 2013 30 Sep 2013 10-Q 29 Oct 2014 2014 Q3
Q2 2013 $189,638,000 $50,050,000 -$3,127,000 -5.9% 01 Apr 2013 30 Jun 2013 10-Q 30 Jul 2014 2014 Q2
Q1 2013 $192,765,000 $47,884,000 -$3,988,000 -7.7% 01 Jan 2013 31 Mar 2013 10-Q 01 May 2014 2014 Q1
Q4 2012 $196,753,000 $45,041,000 +$2,027,000 +4.7% 01 Oct 2012 31 Dec 2012 10-K 23 Feb 2015 2014 FY
Q3 2012 $194,726,000 $46,663,000 -$11,802,000 -20% 01 Jul 2012 30 Sep 2012 10-Q 07 Nov 2013 2013 Q3
Q2 2012 $206,528,000 $53,177,000 +$2,138,000 +4.2% 01 Apr 2012 30 Jun 2012 10-Q 02 Aug 2013 2013 Q2
Q1 2012 $204,390,000 $51,872,000 +$875,000 +1.7% 01 Jan 2012 31 Mar 2012 10-Q 03 May 2013 2013 Q1
Q4 2011 $203,515,000 $43,014,000 +$3,704,000 +9.4% 01 Oct 2011 31 Dec 2011 10-K 25 Feb 2014 2013 FY
Q3 2011 $199,811,000 $58,465,000 +$3,152,000 +5.7% 01 Jul 2011 30 Sep 2011 10-Q 02 Nov 2012 2012 Q3
Q2 2011 $196,659,000 $51,039,000 -$1,123,000 -2.2% 01 Apr 2011 30 Jun 2011 10-Q 27 Jul 2012 2012 Q2
Q1 2011 $197,782,000 $50,997,000 +$1,846,000 +3.8% 01 Jan 2011 31 Mar 2011 10-Q 27 Apr 2012 2012 Q1
Q4 2010 $195,936,000 $39,310,000 01 Oct 2010 31 Dec 2010 10-K 22 Feb 2013 2012 FY
Q3 2010 $55,313,000 01 Jul 2010 30 Sep 2010 10-Q 28 Oct 2011 2011 Q3
Q2 2010 $52,162,000 01 Apr 2010 30 Jun 2010 10-Q 29 Jul 2011 2011 Q2
Q1 2010 $49,151,000 01 Jan 2010 31 Mar 2010 10-Q 29 Apr 2011 2011 Q1

ACCENDRA HEALTH INC/VA/ Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $27,460,000 +$245,190,000 01 Jan 2025 31 Dec 2025 10-K 20 Feb 2026 2025 FY
2024 $217,730,000 -$350,961,000 -263% 01 Jan 2024 31 Dec 2024 10-K 20 Feb 2026 2025 FY
2023 $133,231,000 -$9,682,000 -6.8% 01 Jan 2023 31 Dec 2023 10-K 20 Feb 2026 2025 FY
2022 $142,913,000 -$225,560,000 -61% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
2021 $368,473,000 +$164,355,000 +81% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
2020 $204,118,000 +$130,967,000 +179% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $73,151,000 +$425,497,000 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022 2021 FY
2018 $352,346,000 -$441,597,000 -495% 01 Jan 2018 31 Dec 2018 10-K 04 Mar 2020 2019 FY
2017 $89,251,000 -$110,348,000 -55% 01 Jan 2017 31 Dec 2017 10-K 06 Mar 2019 2018 FY
2016 $199,599,000 -$760,000 -0.38% 01 Jan 2016 31 Dec 2016 10-K 06 Mar 2019 2018 FY
2015 $200,359,000 +$40,823,000 +26% 01 Jan 2015 31 Dec 2015 10-K 23 Feb 2018 2017 FY
2014 $159,536,000 -$38,547,000 -19% 01 Jan 2014 31 Dec 2014 10-K 17 Feb 2017 2016 FY
2013 $198,083,000 +$1,330,000 +0.68% 01 Jan 2013 31 Dec 2013 10-K 25 Feb 2016 2015 FY
2012 $196,753,000 -$6,762,000 -3.3% 01 Jan 2012 31 Dec 2012 10-K 23 Feb 2015 2014 FY
2011 $203,515,000 +$7,579,000 +3.9% 01 Jan 2011 31 Dec 2011 10-K 25 Feb 2014 2013 FY
2010 $195,936,000 01 Jan 2010 31 Dec 2010 10-K 22 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.